Articles

The Mechanism of Hey2 Expression in Cardiac Development

Citation:

European Cardiology Review 2018;13(2):128.

The Role of p53 Localised in Cytosol and Mitochondria During Reprogramming to iPS Cells

Citation:

European Cardiology Review 2018;13(2):127.

A PRMT5 Selective Inhibitor EPZ015666 Suppressed TAC-induced Left Ventricular Dysfunction

Citation:

European Cardiology Review 2018;13(2):130.

TBL1 Suppresses Cardiomyocyte Hypertrophy by Regulating the Interaction Between HDAC3 and GATA4

Citation:

European Cardiology Review 2018;13(2):126.

Relationship Between VEGF-C Levels and All-cause Mortality in Patients with Chronic Heart Failure

Citation:

European Cardiology Review 2018;13(2):129.

Analysis of the Effects of EPA and DHA on Cardiomyocyte hypertrophy

Citation:

European Cardiology Review 2018;13(2):121.

Cavin-2 Deficiency Attenuates Cardiac Fibrosis and Dysfunction in Pressure-overloaded Hearts

Citation:

European Cardiology Review 2018;13(2):120.

The GATA4 Acetylation Site Plays a Key Role in the Development of Cardiomyocyte Hypertrophy

Citation:

European Cardiology Review 2018;13(2):125.

Foreword

Citation:

European Cardiology Review 2018;13(2):90.

Dr Renu Virmani

Citation:

European Cardiology Review 2018;13(2):134–135.